Press releases | WebDisclosure

Basculer en Français

11304	Companies
251226	Keywords
180286	Articles
137080	Press releases

Home
Press releases

PRESS RELEASE

published on 09/30/2024 at 08:00, 2 years 1 month ago

Ondine Biomedical Reports Robust Growth in H1 2024
Ondine Biomedical reports unaudited strong operational and financial results for the first half of 2024, including revenue growth and strategic partnerships

Financial Results Strategic Partnership Ondine Biomedical Operational Highlights Clinical Endeavors
PRESS RELEASE

published on 09/30/2024 at 08:00, 2 years 1 month ago

Résultats semestriels 2024
Transition Evergreen publie ses résultats semestriels avec un ANR de 116,7 M€ au 30 juin 2024, impacté par des taux d'intérêts élevés et des prix de l'énergie bas

Énergies Renouvelables Résultats Semestriels Transition Écologique ANR Transition Evergreen
PRESS RELEASE

published on 09/30/2024 at 07:30, 2 years 1 month ago

Formycon and Fresenius Kabi receive FDA approval for FYB202/ OtulfiTM (ustekinumab-aauz)
Formycon and Fresenius Kabi receive FDA approval for FYB202/OtulfiTM (ustekinumab-aauz) to treat several conditions including Crohn’s disease and psoriasis, expanding biosimilar market presence

FDA Approval Biosimilar Formycon Fresenius Kabi Ustekinumab
PRESS RELEASE

published on 09/30/2024 at 07:30, 2 years 1 month ago

METAVISIO - THOMSON - PUBLICATION DES RESULTATS SEMESTRIELS LE 16 OCTOBRE 2024
METAVISIO - THOMSON Computing présentera ses perspectives 2024 lors de la publication des résultats semestriels le 16 octobre 2024. Détails sur l'entreprise spécialisée en ordinateurs portables

Résultats Semestriels Perspectives 2024 Metavisio THOMSON Computing Ordinateurs Portables
PRESS RELEASE

published on 09/30/2024 at 07:30, 2 years 1 month ago

Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...)
TheraVet annonce un projet de transformation stratégique avec H4Orphan pour devenir leader de la fibrose pulmonaire idiopathique et développer un traitement innovant, accélérant les études cliniques en Belgique

Transformation Stratégique Étude Clinique TheraVet H4Orphan Fibrose Pulmonaire
PRESS RELEASE

published on 09/30/2024 at 07:30, 2 years 1 month ago

Inside Information / Operations of the issuer (acquisitions, sales...)
TheraVet and H4Orphan collaborate on a strategic project to create a leader in idiopathic pulmonary fibrosis, focusing on innovative treatments. Shareholders to vote on Operation in October 2024

Shareholders Vote Strategic Project TheraVet H4Orphan Idiopathic Pulmonary Fibrosis
PRESS RELEASE

published on 09/30/2024 at 07:30, 2 years 1 month ago

Informations privilégiées / Communiqué sur comptes, résultats
AFYREN annonce ses résultats financiers semestriels 2024, avec des ajustements opérationnels pour atteindre la production en continu d'AFYREN NEOXY. Solide assise financière et avancées commerciales marquantes

Résultats Financiers Partenariats Commerciaux Ajustements Opérationnels AFYREN Production En Continu
PRESS RELEASE

published on 09/30/2024 at 07:30, 2 years 1 month ago

Inside Information / Other news releases
Poxel monetizes TWYMEEG® royalties in a USD 50 million deal with OrbiMed. Proceeds to reduce debt and support rare disease activities. Webinars scheduled for investor updates

Webinars Royalties TWYMEEG® Poxel OrbiMed
PRESS RELEASE

published on 09/30/2024 at 07:30, 2 years 1 month ago

Inside Information / News release on accounts, results
AFYREN announces its 2024 half-year financial results, highlighting adjustments needed for continuous production of AFYREN NEOXY products. Solid financial base supports operations with €43 million in cash as of June 2024

Cash Position Financial Base AFYREN Continuous Production 2024 Half-year Financial Results
PRESS RELEASE

published on 09/30/2024 at 07:00, 2 years 1 month ago

Branicks wins REWE as a further anchor tenant for the “Neustadt Centrum” in Halle
Branicks Group AG secures REWE as anchor tenant for Neustadt Centrum in Halle, enhancing the sector mix with a focus on sustainability and aiming for BREEAM certification

Sustainability Branicks Group AG REWE Neustadt Centrum BREEAM Certification

Accesswire

Published on 11/10/2026 at 08:00, 1 hour 49 minutes ago

PEL 82 - QatarEnergy to Acquire 25% Participating Interest from Chevron
Published on 11/10/2026 at 02:45, 7 hours 4 minutes ago

Presentation to Zurich Precious Metals Summit
Published on 11/09/2026 at 23:10, 10 hours 39 minutes ago

Ur-Energy Reports Third Quarter 2026 Results
Published on 11/09/2026 at 23:00, 10 hours 49 minutes ago

LNG Energy Group Announces Issuance of Third Partial Revocation Order and Proposed Shares-for-Debt Settlement
Published on 11/09/2026 at 22:32, 11 hours 17 minutes ago

Announces Extension for Closing of Private Placement of Convertible Promissory Notes

View all ACCESSWIRE

EQS Group

Published on 11/10/2026 at 09:30, 19 minutes ago

Original-Research: DN Group AG (von GBC AG): BUY
Published on 11/10/2026 at 09:15, 34 minutes ago

AssureTrace Appoints Graham Clark as Business Director and Chief Revenue Officer
Published on 11/10/2026 at 09:05, 44 minutes ago

Cepheid Achieves CE Marking Under IVDR for Xpert® Respiratory Panel
Published on 11/10/2026 at 09:05, 44 minutes ago

Jackery Black Friday 2026: Up to 58% Off Explorer v2 Portable Power Stations and Solar Generators, Starting at Just £378
Published on 11/10/2026 at 09:00, 49 minutes ago

Original-Research: q.beyond AG (von NuWays AG): BUY

Les Echos

Published on 11/10/2026 at 07:00, 2 hours 49 minutes ago

bioMérieux receives U.S. FDA 510(k) Clearance and IVDR CE marking for VITEK® PRO, its new automated ID/AST instrument to support the fight against antimicrobial resistance
Published on 11/10/2026 at 07:00, 2 hours 49 minutes ago

bioMérieux obtient l’autorisation 510(k) de la FDA américaine et le marquage CE selon l’IVDR pour VITEK® PRO, son nouvel instrument automatisé d’identification et d’antibiogramme contribuant à la lutte contre l’antibiorésistance
Published on 11/09/2026 at 18:30, 15 hours 19 minutes ago

Air Liquide has successfully issued a CHF 390 million multi-tranche bond
Published on 11/09/2026 at 18:30, 15 hours 19 minutes ago

Air Liquide a réalisé avec succès une émission obligataire multi-tranches de 390 millions de CHF
Published on 11/09/2026 at 17:45, 16 hours 4 minutes ago

Weekly share buyback

View all LES ECHOS COMFI WIRE